Chromosomal breakage correlates with delayed lethality in normal and ataxia telangiectasia cell lines treated with bleomycin

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 372, Issue 1, 1996, Pages 33-42

  MacLeod, Roderick A F ^a   Buchheim, Torsten ^a   Kaufmann, Maren ^a   Drexler, Hans G ^a  

^a DSMZ German Collec of M ^*  (Germany)

Author keywords

Apoptosis; Ataxia telangiectasia; Bleomycin; Chromosomal aberration

Indexed keywords

BLEOMYCIN;

APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LETHALITY; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ATAXIA TELANGIECTASIA; BLEOMYCIN; CELL DEATH; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOZYGOTE; HUMANS; MUTAGENICITY TESTS;

EID: 0030580208     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(96)00106-6     Document Type: Article

References (21)

1. [1] Little, J.B. (1994) Changing views of cellular radiosensitivity, Radiation Res., 140, 299-311.
2. [2] Savitsky, K.A., S. Bar-Shira, G. Gilad, Y. Rotman, L. Ziv, D.A. Vanagaite, S. Tagle, T. Smith, S. Uziel, M. Sfev, I. Ashkenezi, M. Pecker, R. Frydman, S.R. Harnik, A. Patanjali, G.A. Simmmons, G.A. Clines, R.A. Sartiel, L. Gatti, L. Chessa, M.F. Sanal, N.G.J. Lavin, S.R. Jaspers, A.M.R. Taylor, C.F. Arlett, S.M. Miki, M. Weissman, F. Lovett, F.S. Collins and Y. Yhiloh (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase, Science, 269, 1749-1753.
3. [3] Taylor, A.M.R., D.G. Harnden, C.F. Arlett, S.A. Harcourt, A.R. Lehmann, S. Stephens and B.A. Bridges (1975) Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity, Nature, 258, 427-429.
4. 2 ataxia - telangiectasia cells exposed to X-rays and ara-A. Int. J. Radiation Biol., 55, 71-74.
5. 2 lymphocytes treated with bleomycin: comparison with equivalent X-irradiation reveals formation of a novel class of heavily damaged cells. Mutation Res., 309, 73-81.
6. [6] Östling, O. and K.J. Johansson (1987) Bleomycin, in contrast to gamma radiation, induces extreme variation of DNA damage from cell to cell, Int. J. Radiat. Biol., 52, 5, 683-691.
7. [7] Tounekti, O. G. Pron, J. Beledradek and L.M. Mir (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res., 53, 5462-5469.
8. [8] Tounekti, O., J. Beledradek and L.M. Mir (1994) La bleomycine est une agent anticancereux capable de mimer l'apoptose, Bull. Cancer, 81, 1043-1049.
9. [9] Scott, D. and F. Zampetti-Bosseler (1985) Relationship between chromosome damage, cell cycle delay and cell killing induced by bleomycin or X-rays, Mutation Res., 151, 83-88.
10. [10] Zampetti-Bosseler, F. and D. Scott (1985) The response of normal and ataxia-telangiectasia cells to bleomycin: Relationships between chromosome damage and cell killing, Mutation Res., 151, 89-94.
11. [11] Cohen, M.M. and S.J Simpson (3980) Growth kinetics of ataxia-telangiectasia lymphoblastoid cells - Evidence for a prolonged S-phase period, Cytogenet. Cell Genet., 28, 24-33.
12. [12] ISCN (1985) An international system for human cytogenetic nomenclature, Harnden D.G. and H.P. Klinger (Eds.), published in collaboration with Cytogenetics Cell Genet., Karger, Basel.
13. [13] Scott, D., N. Danford, B. Dean, D. Kirkland and C. Richardson (1983) In vitro chromosome aberration assays. In Dean, B. (Ed.), UKEMS Report on Guidelines for Mutagenicity Testing. United Kingdom Environmental Mutagen Society. pp. 41-64.
14. 2 chromatid aberrations in human lymphocytes, Mutagenesis, 7, 285-290.
15. 2-Aberrationskinetik bei normalen und Ataxia Telangiectasia homozygoten und heterozygoten Zellinien. Diplomarbeit, Technische Universität Carolina Wilhelmina, Braunschweig.
16. [16] Miller, K. (1991) Clastogenic effects of bleomycin, cyclophosphamide, and ethylmethanesulfonate on resting and proliferating human B-and T-lymphocytes, Mutation Res., 251, 241-251.
17. 2, Mutation Res., 284, 195-204.
18. [18] Affentranger, M.I. and W. Burkart (1995) Resolution of DNA damage at the single cell level shows largely different actions of X-rays and bleomycin, J. Histochem. Cytochem., 43, 229-235.
19. [19] Akiyama, S.I., K. Ikezaki, H. Kuramochi, K. Takahashi and M. Kuwano (1981) Bleomycin resistant cells contain increased bleomycin hydrolase activities, Biochem. Biophys. Res. Commun., 101, 55-60.
20. [20] Bolzan, A.D., N.O. Bianchi, M.L. Larramendy and M.S. Bianchi (1992) Chromosomal sensitivity of human lymphocytes to bleomycm: Influence of antioxidant enzyme activities in whole blood and different blood fractions, Cancer Genet. Cytogenet., 64, 133-138.
21. [21] Liu, N. and P.E. Bryant (1993) Response of ataxia telangiectasia cells to restriction endonuclease induced DNA double strand breaks: I. Cytogenetic characterization, Mutagenesis, 8, 503-510.